165 related articles for article (PubMed ID: 36256815)
21. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer.
Reichert M; Bakir B; Moreira L; Pitarresi JR; Feldmann K; Simon L; Suzuki K; Maddipati R; Rhim AD; Schlitter AM; Kriegsmann M; Weichert W; Wirth M; Schuck K; Schneider G; Saur D; Reynolds AB; Klein-Szanto AJ; Pehlivanoglu B; Memis B; Adsay NV; Rustgi AK
Dev Cell; 2018 Jun; 45(6):696-711.e8. PubMed ID: 29920275
[TBL] [Abstract][Full Text] [Related]
22. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
[TBL] [Abstract][Full Text] [Related]
23. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.
Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R
Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
25. MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.
Javaid S; Zhang J; Smolen GA; Yu M; Wittner BS; Singh A; Arora KS; Madden MW; Desai R; Zubrowski MJ; Schott BJ; Ting DT; Stott SL; Toner M; Maheswaran S; Shioda T; Ramaswamy S; Haber DA
Mol Cancer Res; 2015 May; 13(5):934-43. PubMed ID: 25678598
[TBL] [Abstract][Full Text] [Related]
26. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
[TBL] [Abstract][Full Text] [Related]
27. Development of a method to isolate circulating tumor cells using mesenchymal-based capture.
Bitting RL; Boominathan R; Rao C; Kemeny G; Foulk B; Garcia-Blanco MA; Connelly M; Armstrong AJ
Methods; 2013 Dec; 64(2):129-36. PubMed ID: 23845299
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance.
Zhou J; Zhu X; Wu S; Guo J; Zhang K; Xu C; Chen H; Jin Y; Sun Y; Zheng S; Chen Y
Cancer Biol Med; 2020 Feb; 17(1):169-180. PubMed ID: 32296584
[No Abstract] [Full Text] [Related]
29. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
30. Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells.
Powan P; Luanpitpong S; He X; Rojanasakul Y; Chanvorachote P
Am J Physiol Cell Physiol; 2017 Nov; 313(5):C556-C566. PubMed ID: 28931539
[TBL] [Abstract][Full Text] [Related]
31. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
32. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
[TBL] [Abstract][Full Text] [Related]
33. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
[TBL] [Abstract][Full Text] [Related]
34. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
35. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
[TBL] [Abstract][Full Text] [Related]
36. Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Togo S; Shimizu H; Saito M
J Transl Med; 2018 Oct; 16(1):287. PubMed ID: 30342534
[TBL] [Abstract][Full Text] [Related]
37. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
38. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
[TBL] [Abstract][Full Text] [Related]
39. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
40. Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state.
Mizukoshi K; Okazawa Y; Haeno H; Koyama Y; Sulidan K; Komiyama H; Saeki H; Ohtsuji N; Ito Y; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
Int J Cancer; 2020 May; 146(9):2547-2562. PubMed ID: 31506938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]